Maartje S Jacobs
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 26, 2022
Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands.Marinus van Hulst, Robert G Tieleman, Lennaert A R Zwart
|Jun 09, 2020
Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit.Maartje S Jacobs, Bert Loef, Auke C Reidinga
|Apr 06, 2019
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions.M S Jacobs, M van Hulst, Z Campmans
|Mar 31, 2018
Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands.Maartje S Jacobs, Jeroen F Schouten, Pieter T de Boer
|Nov 29, 2017
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation.Maartje S Jacobs, Lisa A de Jong, Maarten J Postma
|Aug 25, 2017
The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands.Marinus van Hulst, Jelena Stevanovic, Maartje S Jacobs
Pageof 2
